Processing of Human Intestinal Prolactase to an Intermediate Form by Furin or by a Furin-like Proprotein Convertase [PDF]
José Emilio Mesonero+2 more
openalex +1 more source
Role of PCSK9 inhibitors in the management of dyslipidaemia
Proprotein convertase subtilisin kexin9 (PCSK9) inhibitors are novel agents that lower LDL cholesterol and reduce cardio-vascular event rate. Being expensive, these agents are reserved for those with high risk or very high risk of CV events and with ...
Tiny Nair
doaj
Proprotein Convertase Enzyme Furin as a Biomarker for Immune-Mediated Diseases [PDF]
Immuunivälitteiset sairaudet ovat yleistyvä ongelma väestön ikääntyessä. Tällä hetkellä käytössä olevat biomarkkerit ovat kuitenkin epätarkkoja ja ennustearvoltaan heikkoja, minkä vuoksi tämän potilasryhmän varhainen tunnistaminen ja tehokas hoito on ...
Ranta, Noora
core
Dynamic palmitoylation of lymphoma proprotein convertase prolongs its half-life, but is not essential for trans-Golgi network localization [PDF]
Jan-Willem H. P. VAN DE LOO+5 more
openalex +1 more source
Background Alirocumab is a fully human monoclonal antibody to proprotein convertase subtilisin kexin type 9 used for the reduction of low-density lipoprotein cholesterol (LDL-C) in high-risk patients not reaching their LDL-C target.
Klaus G. Parhofer+6 more
doaj +1 more source
Endoproteolytic processing of integrin pro-α subunits involves the redundant function of furin and proprotein convertase (PC) 5A, but not paired basic amino acid converting enzyme (PACE) 4, PC5B or PC7 [PDF]
Jean‐Claude Lissitzky+7 more
openalex +1 more source
Processing of β-Secretase by Furin and Other Members of the Proprotein Convertase Family [PDF]
John W.M. Creemers+8 more
openalex +1 more source
Background Obesity is associated with airway hyperresponsiveness and lung fibrosis, which may reduce the effectiveness of standard asthma treatment in individuals suffering from both conditions.
Lin Liang+5 more
doaj +1 more source
Transforming hypercholesterolemia management: Spotlight on PCSK9 peptide vaccines
Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a therapeutic target for dyslipidemia and atherosclerotic cardiovascular disease (ASCVD). Two recent studies published by Fang et al.1 and Zhang et al.2 in Cell Reports Medicine and Cell Reports ...
Amirhossein Sahebkar, Maciej Banach
doaj
The proprotein convertase furin is a pro-oncogenic driver in KRAS and BRAF driven colorectal cancer
Zongsheng He+7 more
semanticscholar +1 more source